Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of omecamtiv mecarbil in healthy volunteers of Japanese and non-Japanese ethnicity

Next Previous
Trial Profile

Phase I trial of omecamtiv mecarbil in healthy volunteers of Japanese and non-Japanese ethnicity

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 20 Aug 2021 Results of two clinical studies evaluating pharmacokinetics, tolerability, and safety of single and multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian subjects published in the European Journal of Drug Metabolism and Pharmacokinetics
  • 27 Oct 2014 Top-line results published in a Cytokinetics media release.
  • 27 Oct 2014 Status changed from recruiting to completed, as reported by a Cytokinetics media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top